Company page

Cellectar Biosciences, Inc.

Cellectar Biosciences, Inc. (ticker: CLRB) is a public company based in the United States, specializing in the development of targeted therapies for cancer. With a market capitalization of approximately $19.3 million, Cellectar focuses on innovative treatments aimed at improving patient outcomes. The company is committed to advancing its proprietary drug delivery platform to enhance the effectiveness of cancer therapies.